LUNGevity Foundation/LinkedIn
Feb 6, 2025, 10:51
Start a conversation with your patients about the importance of biomarker testing – LUNGevity Foundation
LUNGevity Foundation shared a post on LinkedIn:
“Healthcare providers – testing for all clinically recommended biomarkers is a critical step for your non-small cell lung cancer patients.
The results of comprehensive biomarker testing can help inform their treatment that may prevent their NSCLC from growing or spreading.
Tomorrow is World Cancer Day, take this time to start a conversation with your patients about the importance of biomarker testing. Discover our resources for more information.”
Proceed to the video attached to the post.
More posts featuring LUNGevity Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 8, 2025, 17:30
May 8, 2025, 15:53
May 8, 2025, 15:14
May 8, 2025, 15:13